Clinical Trial Update: Vitamin D3 for the Treatment of Low Vitamin D in Cystic Fibrosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Vitamin D3 for treating vitamin D deficiency in cystic fibrosis patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Vitamin Deficiency

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Cystic Fibrosis, Vitamin D Deficiency | Phase 3 | Status: WITHDRAWN